Medicare billing address
CMS Medicare provider billing file
9500 Euclid AvenueCleveland, OH 44195
CMS public data · NPI 1184933608
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Yasha S Modi, M.D.
Specialty
Credential
M.D.
NPI
1184933608
Primary source state
OH
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Yasha S Modi, M.D. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
9500 Euclid AvenueCMS Doctors & Clinicians file
111 BroadwayCMS Doctors & Clinicians file
210 E 64Th StCMS Doctors & Clinicians file
240 E 38Th StIn the 2024 CMS provider billing file, this NPI had 1,027 Medicare beneficiaries and 19,400 total services. The average beneficiary age was 75, and the average HCC risk score was 1.3.
Total Medicare allowed amount
$2,013,578.29
Total Medicare payment amount
$1,575,498.43
Medicare beneficiaries
1,027
Total services
19,400
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
72%
CMS beneficiary-panel share
Diabetes
40%
CMS beneficiary-panel share
Ischemic heart disease
35%
CMS beneficiary-panel share
Chronic kidney disease
21%
CMS beneficiary-panel share
Osteoporosis
18%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, faricimab-svoa, 0.1 mg | 11,040 | $34.27 |
| Imaging of retina | 1,956 | $44.03 |
| Injection, aflibercept, 1 mg | 1,090 | $824.17 |
| Extended exam of the back part of the eye with retinal drawing | 1,025 | $26.94 |
| Injection of drug into eye | 851 | $135.94 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 726 | $140.31 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 583 | $98.42 |
| Established patient complete exam of visual system | 341 | $137.49 |
| Injection, dexamethasone, intravitreal implant, 0.1 mg | 315 | $191.89 |
| Photography of the retina | 217 | $38.05 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1184933608. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 457 | 932.3 | $6,162.65 |
| 2 | Latanoprost | Latanoprost | 370 | 710 | $4,359.88 |
| 3 | Prednisolone Acetate | Prednisolone Acetate | 338 | 452.9 | $14,924.38 |
| 4 | Ketorolac Tromethamine | Ketorolac Tromethamine | 219 | 306 | $5,750.74 |
| 5 | Brimonidine Tartrate | Brimonidine Tartrate | 141 | 240.1 | $7,814.80 |
| 6 | Timolol Maleate | Timolol Maleate | 86 | 191.4 | $1,572.65 |
| 7 | Fluorometholone | Fluorometholone | 70 | 113 | $5,378.59 |
| 8 | Difluprednate | Difluprednate | 68 | 76.6 | $7,719.06 |
| 9 | Bromfenac Sodium | Bromfenac Sodium | 62 | 73.4 | $9,550.10 |
| 10 | Ofloxacin | Ofloxacin | 53 | 54.7 | $457.02 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Yale University School Of Medicine
Graduation year
2011
Group/practice field
New York University
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.